Table 2.
Review of the English literature on ceruminal adenocarcinoma [4, 5, 10, 12, 14, 16–18, 29–32, 38–66]a
| Characteristics | Ceruminous carcinoma Total: N = 91 |
|---|---|
| Gender | |
| Women | 54 |
| Men | 37 |
| Age (in years) | |
| Range | 21–92 |
| Mean | 49.0 |
| Women (mean) | 49.7 |
| Men (mean) | 48.0 |
| Symptom duration (in months)b | |
| Range | 1–444 |
| Mean | 51.6 |
| Women (mean) | 41.7 |
| Men (mean) | 64.4 |
| Symptoms at presentationb,c | |
| Pain (otalgia) | 48 |
| Mass | 34 |
| Hearing changes (loss, tinnitus) | 33 |
| Drainage, discharge, bleeding | 31 |
| Nerve changes (paralysis, paresthesias) | 7 |
| Location (n = 72)b | |
| Left | 39 |
| Right | 33 |
| Size (in cm)b | |
| Range | 0.5–3.0 |
| Mean | 1.41 |
| Median | 1.3 |
| Tumor histology: | |
| Adenoid cystic carcinoma | 64 |
| Adenocarcinoma, ceruminous | 22 |
| Mucoepidermoid carcinoma | 4 |
| Sebaceous carcinoma | 1 |
| All patients with follow-up (n = 81) (months) | 83.9 (mean) |
| Follow-up range | 1–348 |
| Alive, no evidence of disease (n = 37) | 68.6 (5.7 years) |
| Alive, with disease (n = 13) | 108.5 (9.0 years) |
| Dead, no evidence of disease (n = 6) | 154.0 (12.8 years) |
| Dead, with disease (n = 25) | 77.0 (6.4 years) |
| Alive/Dead, no evidence of disease (n = 43) | 80.5 (6.7 years) |
| Alive/Dead, with disease (n = 38) | 87.7 (7.3 years) |
| Patient outcome by tumor histology:b | |
| Adenocarcinoma, ceruminousb (n = 20) | 55.9 (4.7 years) |
| Adenoid cystic carcinomab (n = 56) | 99.8 (8.3 years) |
| Mucoepidermoid carcinomab (n = 4) | 18.5 (1.5 years) |
| Patient outcome for patients with recurrence (n = 49) | 102.6 (8.5 years) |
| Patient outcome for patients without recurrence (n = 32) | 55.3 (4.6 years) |
a This table does not include the series reported in this study
b Parameter was not stated in all cases
c Patients may have experienced more than one symptom